These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28256068)
1. Correlation between Trop2 and amphiregulin coexpression and overall survival in gastric cancer. Zhao W; Ding G; Wen J; Tang Q; Yong H; Zhu H; Zhang S; Qiu Z; Feng Z; Zhu J Cancer Med; 2017 May; 6(5):994-1001. PubMed ID: 28256068 [TBL] [Abstract][Full Text] [Related]
2. Trop2 is overexpressed in gastric cancer and predicts poor prognosis. Zhao W; Zhu H; Zhang S; Yong H; Wang W; Zhou Y; Wang B; Wen J; Qiu Z; Ding G; Feng Z; Zhu J Oncotarget; 2016 Feb; 7(5):6136-45. PubMed ID: 26716416 [TBL] [Abstract][Full Text] [Related]
3. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer. Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714 [TBL] [Abstract][Full Text] [Related]
4. Abnormal amphiregulin expression correlates with gastric cancer prognosis. Wang B; Yong H; Zhu H; Ni D; Tang S; Zhang S; Wang W; Zhou Y; Zhao W; Ding G; Zhu J; Li X; Feng Z Oncotarget; 2016 Nov; 7(47):76684-76692. PubMed ID: 27713123 [TBL] [Abstract][Full Text] [Related]
5. Over expression of amphiregulin promoted malignant progression in gastric cancer. Jiang J; Zhao W; Tang Q; Wang B; Li X; Feng Z Pathol Res Pract; 2019 Oct; 215(10):152576. PubMed ID: 31466817 [TBL] [Abstract][Full Text] [Related]
6. TROP2 expression as prognostic marker for gastric carcinoma. Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986 [TBL] [Abstract][Full Text] [Related]
7. Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer. Ichikawa W; Terashima M; Ochiai A; Kitada K; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M Gastric Cancer; 2017 Mar; 20(2):263-273. PubMed ID: 26884344 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
9. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer. Zhao W; Kuai X; Zhou X; Jia L; Wang J; Yang X; Tian Z; Wang X; Lv Q; Wang B; Zhao Y; Huang W Oncol Rep; 2018 Aug; 40(2):759-766. PubMed ID: 29901160 [TBL] [Abstract][Full Text] [Related]
10. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes. Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of TROP2 expression in patients with gallbladder cancer. Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430 [TBL] [Abstract][Full Text] [Related]
12. Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa. Riera KM; Jang B; Min J; Roland JT; Yang Q; Fesmire WT; Camilleri-Broet S; Ferri L; Kim WH; Choi E; Goldenring JR J Pathol; 2020 Jul; 251(3):336-347. PubMed ID: 32432338 [TBL] [Abstract][Full Text] [Related]
13. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma. Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366 [TBL] [Abstract][Full Text] [Related]
14. Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Kuai X; Jia L; Yang T; Huang X; Zhao W; Zhang M; Chen Y; Zhu J; Feng Z; Tang Q Med Sci Monit; 2020 Jan; 26():e919566. PubMed ID: 31964857 [TBL] [Abstract][Full Text] [Related]
15. TROP2 Down-regulated DSG2 to Promote Gastric Cancer Cell Invasion and Migration by EGFR/AKT and DSG2/PG/β-Catenin Pathways. Yang T; Jia L; Bian S; Chang X; Zhang Q; Tang Q; Zhu J; Yang Z; Feng Z Curr Cancer Drug Targets; 2022 Aug; 22(8):691-702. PubMed ID: 35392784 [TBL] [Abstract][Full Text] [Related]
16. Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma. Wang L; Wu H; Wang L; Lu J; Duan H; Liu X; Liang Z Diagn Pathol; 2016 Jul; 11(1):60. PubMed ID: 27391842 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of increased expression of RBM8A in gastric cancer. Lv X; Cheng H Braz J Med Biol Res; 2020; 53(4):e9290. PubMed ID: 32294703 [TBL] [Abstract][Full Text] [Related]
18. L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients. Wang YY; Li L; Zhao ZS; Wang YX; Ye ZY; Tao HQ J Exp Clin Cancer Res; 2013 Sep; 32(1):66. PubMed ID: 24422715 [TBL] [Abstract][Full Text] [Related]
19. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828 [TBL] [Abstract][Full Text] [Related]
20. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]